Nanoantidote for repression of acidosis pH promoting COVID‐19 infection
Qidong Liu, Huitong Ruan, Zhihao Sheng, Xiaoru Sun, Siguang Li, Wenguo Cui, Cheng Li
VIEW, doi:10.1002/viw.20220004
Acidosis, such as respiratory acidosis and metabolic acidosis, can be induced by coronavirus disease 2019 (COVID-19) infection and is associated with increased mortality in critically ill COVID-19 patients. It remains unclear whether acidosis further promotes SARS-CoV-2 infection in patients, making virus removal difficult. For antacid therapy, sodium bicarbonate poses great risks caused by sodium overload, bicarbonate side effects, and hypocalcemia. Therefore, new antacid antidote is urgently needed. Our study showed that an acidosis-related pH of 6.8 increases SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) expression on the cell membrane by regulating intracellular microfilament polymerization, promoting SARS-CoV-2 pseudovirus infection. Based on this, we synthesized polyglutamic acid-PEG materials, used complexation of calcium ions and carboxyl groups to form the core, and adopted biomineralization methods to form a calcium carbonate nanoparticles (CaCO 3 -NPs) nanoantidote to neutralize excess hydrogen ions (H + ), and restored the pH from 6.8 to approximately 7.4 (normal blood pH). CaCO 3 -NPs effectively prevented the heightened SARS-CoV-2 infection efficiency due to pH 6.8. Our study reveals that acidosis-related pH promotes SARS-CoV-2 infection, which suggests the existence of a positive feedback loop in which SARS-CoV-2 infection-induced acidosis enhances SARS-CoV-2 infection. Therefore, antacid therapy for acidosis COVID-19 patients is necessary. CaCO 3 -NPs may become an effective antacid nanoantidote superior to sodium bicarbonate.
C O N F L I C T O F I N T E R E S T The authors declare that there is no conflict of interest.
O R C I D Zhihao Sheng https://orcid.org/0000-0002-6675-1400
R E F E R E N C E S
References
Accili, None, Nat Metab
Ackermann, Verleden, Kuehnel, Haverich, Welte et al., None, N Engl J Med
Adeva-Andany, Fernandez-Fernandez, Mourino-Bayolo, Castro-Quintela, Dominguez-Montero, None, Sci World J
Aid, Busman-Sahay, Vidal, Maliga, Bondoc et al., None, Cell
Blondin, Sapountzi, Maciver, Lagarrigue, Benyamin et al., None, Eur J Biochem
Cai, Saiding, Cheng, Zhang, Wang et al., None, Bioact Mater
Cai, Xu, Chen, Wang, Zhao, None, Eng Regen
Chand, Swenson, Goldfarb, None, Curr Opin Nephrol Hypertens
Chen, Wang, Zhang, Chen, Hu et al., None, Nat Nanotechnol
Chirinos, Cohen, Zhao, Hanff, Sweitzer et al., None, Hypertension
Colmenero, Santonja, Alonso-Riano, Noguera-Morel, Hernandez-Martin et al., None, Br J Dermatol
Constable, None, Vet Clin North Am Food Anim Pract
Evans, Rainger, Mason, Guzik, Osto et al., None, Cardiovasc Res
Farokhzad, Tao, None, Trends Chem
Fielding-Singh, Matthay, Calfee, None, Crit Care Med
Frey, Kline, Foreman, Lyman, None, J Anim Sci
Gallop, None, Semin Cell Dev Biol
Gao, Ding, Dong, Zhang, Kursat Azkur et al., None, Allergy
Gheblawi, Wang, Viveiros, Nguyen, Zhong et al., None, Circ Res
Guan, Ni, Hu, Liang, Ou et al., China Medical Treatment Expert Group for COVID-19, N Engl J Med
Hawkins, Pope, Maciver, Weeds, None, Biochemistry
Hollstein, Schulte, Schulz, Gluck, Ziegler et al., None, Nat Metab
Holzinger, None, Methods Mol Biol
Jaber, Paugam, Futier, Lefrant, Lasocki et al., None, Lancet
Kraut, Madias, None, Nat Rev Nephrol
Li, Wang, Chen, Zuo, Zhang et al., None, Diabetes Obes Metab
Liu, Bi, Sun, Wang, Yu et al., None, Mater Sci Eng C Mater Biol Appl
Liu, Cai, Wang, Hong, Deng et al., None, Adv Sci
Liu, Xu, Cui, Zhang, None, Eng Regen
Ma, Zhu, Zhang, Qian, Wang et al., None, VIEW
Maleki Dizaj, Barzegar-Jalali, Zarrintan, Adibkia, Lotfipour, None, Expert Opin Drug Deliv
Milewska, Nowak, Owczarek, Szczepanski, Zarebski et al., None, J Virol
Monteil, Kwon, Prado, Hagelkruys, Wimmer et al., None, Cell
Nishiyama, Okazaki, Cabral, Miyamoto, Kato et al., None, Cancer Res
Ogunlade, Guidry, Mukerjee, Sriramula, Lazartigues et al., None, Cell Mol Neurobiol
Palermo, Sadhu, Mcdonnell, None, J Clin Endocrinol Metab
Patel, Ahmed, Gunapalan, Hesselbacher, None, World J Diabetes
Quade, Parker, Occhipinti, None, Biochem Pharmacol
Rabie, Azzam, Al-Fares, Abdelbary, Mufti et al., None, Intensive Care Med
Rauf, Tasleem, Bhise, Tatiparti, Sau et al., None, View
Ruan, Hu, Wen, Chen, Chen et al., None, Adv Mater
Ruan, Hu, Wen, Chen, Chen et al., None, Adv Mater
Smith, Sausville, Girish, Yuan, Vasudevan et al., None, Dev Cell
Som, Raliya, Tian, Akers, Ippolito et al., None, Nanoscale
South, Diz, Chappell, None, Am J Physiol Heart Circ Physiol
Stevens, Bogun, Mcmahon, Zucker, Kurlansky et al., None, Diabetes Metab
Tang, Kong, Zhang, Liu, Hu et al., None, Nat Rev Mater
Tang, Zhang, Shu, Guo, Zhang et al., None, Nano Today
Torres, Alcubilla, Gonzalez-Cordon, Inciarte, Chumbita et al., None, Int J Infect Dis
Verdecchia, Cavallini, Spanevello, Angeli, None, Eur J Intern Med
Wang, Xiang, Lin, Cai, Ruan et al., None, Matter
Wu, Mcgoogan, None, JAMA
Xia, Sriramula, Chhabra, Lazartigues, None, Circ Res
Xie, Ma, Tang, Liu, None, Front Public Health
Yamaguchi, Hamano, Doi, Oka, Kajimoto et al., None, Sci Rep
Yan, Zhang, Li, Xia, Guo et al., None, Science
Yang, Cai, Luo, Zhu, Hu et al., None, Crit Care Med
Yang, Yu, Wang, Wang, Shang, None, Eng Regen
Yang, Yu, Xu, Shu, Xia et al., None, Lancet Respir Med
Zhang, Wang, Liang, Feng, Deng et al., None, PLoS One
Zhao, Li, Ruan, Chen, Cai et al., None, ACS Nano
Zhuang, Cheng, Zhang, Jiang, Wang et al., None, J Med Virol
Ziegler, Allon, Nyquist, Mbano, Miao et al., HCA Lung Biological Network, Cell
